Invitae launches first CE-IVD cancer testing kits in Europe
February 16, 2022Research and Development
Invitae, leading medical genetics company, announced the availability of FusionPlex Dx and LiquidPlex Dx in Europe.With this development, the company …
AstraZeneca COVID-19 vaccine’s short shelf life inhibits rollout to poor countries
February 16, 2022Research and Development
According to officials and WHO documents, the short shelf life of the AstraZeneca COVID-19 vaccine is complicating the rollout to …
Scientists possibly cure HIV in first-time breakthrough for virus
February 16, 2022Research and Development
An American research team appear to have cured HIV in a woman for the first time, making her the third …
Moderna launch Omicron-specific UK vaccine study
February 16, 2022Research and Development
Around 3,000 British volunteers are being sought to take part in a new study for Moderna’s Omicron booster vaccine. The …
Astellas and Seagen announce results of study into muscle-invasive bladder cancer
February 15, 2022Medical Communications
Astellas Pharma and Seagen announced the initial results from Cohort H of their EV-103 trial. This investigated PADDCEV (enfortumab vedotin-ejfv) …
Genuv partners with Aiforia for AI-Powered Drug Screening Platform
February 15, 2022Manufacturing and Production
Genuv has announced an agreement with the medical technology company Aiforia Technologies, to add Aiforia’s AI deep learning for medical …
NICE recommends new diagnostic devices for men with suspected prostate cancer
February 15, 2022Medical Communications
NICE have recommended four new diagnostic devices for men with suspected prostate cancer, which reduce the chances of biopsy related …
‘Game-changing’ South African mRNA hub set to be a foundation for self-reliance
February 15, 2022Manufacturing and Production
WHO officials have visited a number of public and private sector partners that are collaborating to develop and build WHO’s …
FDA approves Eversense CGM system for use for up to six months
February 14, 2022Sales and Marketing
The FDA has approved Senseonics’ Eversense E3 CGM System, which includes proprietary sacrificial boronic acid (SBA) technology to extent longevity …
AbbVie submits applications for treatment of chronic disease
February 14, 2022Sales and Marketing
AbbVie has announced the submission of applications seeking the approval of upadacitinib, (RINVOQ®, 15 mg once daily) for the treatment …
Gilead’s HIV treatment demonstrates high efficacy and viral suppression at five years
February 14, 2022Sales and Marketing
Gilead Sciences has announced the presentation of cumulative five-year results from two Phase III studies of Biktarvy. The new, long-term …
First UK Lassa fever death in over a decade
February 14, 2022Sales and Marketing
A patient in Bedfordshire has died from a confirmed case of Lassa fever, the UK Health Security Agency (UKHSA) has …
Risk of new heart problems raised after COVID-19
February 11, 2022Medical Communications
A large study has found that long after recovery from COVID-19, people continue to face significantly higher risks for new …
Novavax COVID-19 vaccine meets trial endpoints
February 11, 2022Medical Communications
Novavax has announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, achieved its primary effectiveness endpoint in the paediatric expansion …
Sickest patients face record long waits for hospital bed
February 11, 2022Medical Communications
According to NHS data, the sickest patients are facing record long waits for a bed upon admission to hospital in …
Researchers find molecular treatment works against metastatic cancer spread to the brain
February 11, 2022Medical Communications
According to a study published in Clinical Cancer Research, scientists at Mount Sinai conducting clinical trials of a drug targeting …
First biologic medicine approved in China for lupus
February 10, 2022Business Services
Nearly half a million people in China have systematic lupus erythematosus (SLE), and more than have of this number will …
COVID-19 isolation law could end this month in England
February 10, 2022Business Services
Boris Johnson has said that all remaining COVID-19 restrictions in England – including the legal rule to self-isolate – could …
AI support tool aims to change skin cancer treatment in the NHS
February 10, 2022Business Services
Chelsea and Westminster Hospital NHS Foundation Trust has announced the expansion of its partnership with Skin Analytics, with the roll …
FDA accepts Dupixent (dupilumab) for children with moderate-to-severe atopic dermatitis
February 10, 2022Business Services
The FDA has accepted the supplemental Biologics License Application (sBLA) for Dupixent (dupilumab) for children aged six months to five …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
